Biotechnology

Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference

June 2, 2023 4:30 PM

BOSTON, MA / ACCESSWIRE / June 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory and cancer diseases, today announced that Stephen Yoder, president and chief executive officer of Pieris, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 10:00 a.m. ET...

Read more

Hemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-T

June 2, 2023 7:00 AM

Hemogenyx Pharmaceuticals Announces Clinical Hold on IND for HEMO-CAR-T LONDON, UK / ACCESSWIRE / June 2, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company has received a notice from the U.S. Food and Drug Administration ("FDA") regarding the Investigational New Drug ("IND") application forthe Company's product candidate Chimeric...

Read more

BioInvent Obtains IND Approval for Clinical Trial with anti-TNFR2 Antibody BI-1910

June 2, 2023 2:20 AM

LUND, SWEDEN / ACCESSWIRE / June 2, 2023 / BioInvent International (STO:BINV) A differentiated -agonist- approach from BI-1808, the first-in-class antibody currently in phase 1 clinical development Phase 1/2a study of BI-1910 as single agent and in combination with pembrolizumab Exploratory cohorts planned in hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) Five drug candidates in six clinical trials, reflecting the high...

Read more

DiviTum(R) TKa Results to be Presented at ASCO

June 1, 2023 10:15 AM

UPPSALA, SE / ACCESSWIRE / June 1, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, today announces that a poster with DiviTum® TKa results from the SWOG study S0226 will be presented at the the world's largest cancer conference, the annual ASCO meeting, on Sunday, June 4. The data supports the use of DiviTum TKa as a unique biomarker test that provides important clinical information about...

Read more

NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies

June 1, 2023 8:40 AM

CLEVLAND, OH / ACCESSWIRE / June 1, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the formation of its Precision Medicine Division to enable more enhanced and accelerated personalized therapeutics and treatment protocols. Using AI, Big Data and Predictive technologies to power its new Precision Medicine Division, NovAccess Global will search through...

Read more

Third-Party Valuation Firm Provides Estimated Valuation of ByoPlanet's (A Subsidiary Of Plandai – $PLPL) Business and Assets

May 31, 2023 5:30 PM

ATHENS, GA / ACCESSWIRE / May 31, 2023 / ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. (the "Company,") (OTC PINK:PLPL), a leading innovator in revolutionary cleaning technology, announced the completion of a third-party valuation firm's estimates of ByoPlanet's business and assets based on ByoPlanet's unaudited financial statements and internal projections. The third-party firm reviewed and analyzed ByoPlanet's 2020-2022...

Read more

Eyam Announces Artificial Intelligence Research Facility in Partnership with Mitacs

May 31, 2023 2:30 PM

VANCOUVER, BC / ACCESSWIRE / May 31, 2023 / Eyam announces today the opening of a new research facility in partnership with Mitacs, a national not-for-profit organization that empowers innovation through effective partnerships that deliver solutions to the world's most pressing problems. Eyam's new facility, Sentinel AI: Office of Pandemic Preparedness, will be dedicated to the preparation of the next pandemics by advancing the design of...

Read more

Byoplanet Unveils Bold Roadmap for the Upcoming Year, Under the Leadership of CEO Rick O'Shea

May 31, 2023 8:00 AM

ATHENS, GA / ACCESSWIRE / May 31, 2023 / ByoPlanet (OTC PINK:PLPL), a wholly owned subsidiary of Plandai Biotechnology, Inc. and a leading provider of innovative disinfection and building services solutions, announced today its strategic vision for the upcoming year, as the company gears up for rapid growth and expansion following its successful share exchange agreement with Plandai. With a fiscal year end of June 30th, ByoPlanet is poised to...

Read more

Moolec Science Presents Third Quarter FY 2023 Business Update

May 30, 2023 4:30 PM

LUXEMBOURG / ACCESSWIRE / May 30, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023. The main highlights of the Company's business update are as follows: On January 3, the Company started trading on Nasdaq under tickers "MLEC" for the common...

Read more

VoluMetrix Awarded $3 Million NIH SBIR Phase IIb Grant to Propel Development of Non-Invasive Heart Failure Monitoring, NIVA|HF

May 30, 2023 10:00 AM

NASHVILLE, TN / ACCESSWIRE / May 30, 2023 / VoluMetrix, a Nashville-based biotech startup dedicated to creating a new wave of solutions for vital monitoring to enhance well-being, announced today that it has been awarded a Phase IIb Small Business Innovation Research (SBIR) grant expected to total $3 million over three years from the National Heart, Lung and Blood Institute, part of the National Institute of Health. This grant, in conjunction...

Read more

Lab Automation Trailblazers Release New Direct Printer for Life Sciences

May 30, 2023 9:00 AM

Fast and efficient labeling solution for life sciences releases new generation of inkjet direct printer to facilitate scientific discovery. AUSTIN, TX / ACCESSWIRE / May 30, 2023 / Today, TubeWriter, the first company to offer a system for direct printing on labware, announced that they have released a new and improved model of their direct printing solution. After over a decade of providing a fast and efficient labeling solution for life...

Read more

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

May 30, 2023 8:05 AM

TAMPA, FL / ACCESSWIRE / May 30, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies, and CohBar, Inc. (NASDAQ: CWBR) ("CohBar"), today announced that Morphogenesis' abstract has been accepted for poster presentation at the 2023 American Society of Clinical...

Read more

Nascent Biotech Regains Worldwide Rights for Pritumumab

May 26, 2023 5:45 PM

NORTH PALM BEACH, FL / ACCESSWIRE / May 26, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company whose business is focused in therapeutic monoclonal antibody space, announced today that the Company and China based BioRay Pharmaceutical Co have mutually agreed to terminate the license agreement entered into on March 31, 2021. Nascent gains back worldwide marketing and...

Read more

Dermata Therapeutics Announces Closing of $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules

May 26, 2023 4:00 PM

SAN DIEGO, CA / ACCESSWIRE / May 26, 2023 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (Nasdaq:DRMA; DRMAW), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced the closing of its previously announced registered direct offering of an aggregate of 800,877 shares of its common stock (or common stock equivalents in lieu thereof), at a purchase price of...

Read more

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

May 25, 2023 9:00 AM

WESTPORT, CT / ACCESSWIRE / May 25, 2023 / Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA, last week. The platform's precision signal-capturing technology is meant to improve the speed, accuracy and precision of cardiac ablation, a widely-used surgery to treat atrial fibrillation. All three...

Read more

ByoPlanet's bCOOL(TM) Cooling Technology Enhances Performance and Recovery for Major League and College Teams

May 25, 2023 8:00 AM

ATHENS, GA / ACCESSWIRE / May 25, 2023 / ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. (OTC PINK:PLPL), a leading provider of innovative cleaning and disinfection solutions, is proud to announce the utilization of its groundbreaking bCOOL™ cooling technology by major league and college sports organizations. The bCOOL™ device, powered by ByoPlanet's patented technology, revolutionizes heat-related conditions by spraying a...

Read more

AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety

May 25, 2023 7:03 AM

WEST JEFFERSON, OH / ACCESSWIRE / May 25, 2023 / AmplifyBio, an organization built from a preclinical CRO, launched out of Battelle in 2021 and dedicated to building a full-service advanced therapy commercialization hub, is proud to celebrate its two-year anniversary. Since its inception, AmplifyBio has been committed to improving the speed and cost-effectiveness of bringing safe, efficacious therapeutics to patients. Over the past two years,...

Read more

BioInvent and Transgene Report Positive Phase 1a Data on Oncolytic Virus BT-001 in Solid Tumors

May 25, 2023 1:50 AM

LUND, SE / ACCESSWIRE / May 25, 2023 / BioInvent International (STO:BINV) Treatment of all Phase 1a cohorts in monotherapy completed with no safety concerns Stabilization of injected lesions in 11/18 patients An independent Safety Review Committee has approved initiation of the combination trial with pembrolizumab Lund, Sweden and Strasbourg, France - May 25, 2023 - BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech...

Read more

Moolec Science to Host Third Quarter FY 2023 Business Update Call

May 24, 2023 4:00 PM

LUXEMBOURG / ACCESSWIRE / May 24, 2023 / Moolec Science SA (NASDAQ: MLEC; "Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the third quarter of fiscal year 2023 on Tuesday, May 30, 2023, after the market closes. Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López...

Read more

Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts

May 24, 2023 12:20 PM

WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as...

Read more